In vivo, it has been shown that administration of PEGylated IFN-λ1 prevented Balb/c mice from losing weight and led to reduced SARS-CoV-2 lung titers on the second day post-infection; this was true in both a prophylactic scheme (treatment before infection) and a therapeutic scheme (treatment following infection) [70]. Here, IFNL1 is linked to infection.